Acorah Software Products - Accounts Production 16.1.300 false true 31 July 2023 1 August 2022 false 1 August 2023 31 July 2024 31 July 2024 08631065 Dr Stephen Smith Miss Bei Su Mr Harvey Dettmar iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08631065 2023-07-31 08631065 2024-07-31 08631065 2023-08-01 2024-07-31 08631065 frs-core:CurrentFinancialInstruments 2024-07-31 08631065 frs-core:ComputerEquipment 2024-07-31 08631065 frs-core:ComputerEquipment 2023-08-01 2024-07-31 08631065 frs-core:ComputerEquipment 2023-07-31 08631065 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-07-31 08631065 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2023-08-01 2024-07-31 08631065 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2023-07-31 08631065 frs-core:InvestmentPropertyIncludedWithinPPE 2023-08-01 2024-07-31 08631065 frs-core:PlantMachinery 2024-07-31 08631065 frs-core:PlantMachinery 2023-08-01 2024-07-31 08631065 frs-core:PlantMachinery 2023-07-31 08631065 frs-core:SharePremium 2024-07-31 08631065 frs-core:ShareCapital 2024-07-31 08631065 frs-core:RetainedEarningsAccumulatedLosses 2024-07-31 08631065 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 08631065 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 08631065 frs-bus:SmallEntities 2023-08-01 2024-07-31 08631065 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 08631065 frs-bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 08631065 frs-bus:Director1 2023-08-01 2024-07-31 08631065 frs-bus:Director2 2023-08-01 2024-07-31 08631065 frs-bus:CompanySecretary1 2023-08-01 2024-07-31 08631065 frs-countries:EnglandWales 2023-08-01 2024-07-31 08631065 2022-07-31 08631065 2023-07-31 08631065 2022-08-01 2023-07-31 08631065 frs-core:CurrentFinancialInstruments 2023-07-31 08631065 frs-core:SharePremium 2023-07-31 08631065 frs-core:ShareCapital 2023-07-31 08631065 frs-core:RetainedEarningsAccumulatedLosses 2023-07-31
Registered number: 08631065
Clearsky Medical Diagnostics Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2024
Unaudited Financial Statements
Contents
Page
Statement of Financial Position 1—2
Notes to the Financial Statements 3—5
Page 1
Statement of Financial Position
Registered number: 08631065
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 9,566 78,994
Tangible Assets 5 848 1,534
10,414 80,528
CURRENT ASSETS
Debtors 6 53 680
Cash at bank and in hand 46,458 23,513
46,511 24,193
Creditors: Amounts Falling Due Within One Year 7 (14 ) (12,572 )
NET CURRENT ASSETS (LIABILITIES) 46,497 11,621
TOTAL ASSETS LESS CURRENT LIABILITIES 56,911 92,149
PROVISIONS FOR LIABILITIES
Deferred Taxation (161 ) (291 )
NET ASSETS 56,750 91,858
CAPITAL AND RESERVES
Called up share capital 8 134 134
Share premium account 469,975 469,975
Income Statement (413,359 ) (378,251 )
SHAREHOLDERS' FUNDS 56,750 91,858
Page 1
Page 2
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
On behalf of the board
Dr Stephen Smith
Director
13/02/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Clearsky Medical Diagnostics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08631065 . The registered office is The Catalyst, Baird Lane, York, YO10 5GA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Intellectual Property
Intellectual property assets are Patents. They are amortised to the Profit and Loss account over their estimated economic lives of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 25%
Computer Equipment 25%
2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
...CONTINUED
Page 3
Page 4
2.6. Taxation - continued
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2023: 3)
3 3
4. Intangible Assets
Intellectual Property
£
Cost
As at 1 August 2023 143,629
Additions 3,229
Disposals (106,817 )
As at 31 July 2024 40,041
Amortisation
As at 1 August 2023 64,635
Provided during the period 1,070
Disposals (35,230 )
As at 31 July 2024 30,475
Net Book Value
As at 31 July 2024 9,566
As at 1 August 2023 78,994
5. Tangible Assets
Plant & Machinery Computer Equipment Total
£ £ £
Cost
As at 1 August 2023 841 5,375 6,216
As at 31 July 2024 841 5,375 6,216
Depreciation
As at 1 August 2023 841 3,841 4,682
Provided during the period - 686 686
As at 31 July 2024 841 4,527 5,368
Net Book Value
As at 31 July 2024 - 848 848
As at 1 August 2023 - 1,534 1,534
Page 4
Page 5
6. Debtors
2024 2023
£ £
Due within one year
VAT 53 680
53 680
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 14 2,095
Net wages - 8
Other creditors (Current liabilities - creditors < 1 year) - 10,199
Accruals and deferred income - 270
14 12,572
8. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 134 134
Page 5